IDNK gluconokinase, also known as glucose-inhibited division protein kinase (IDNK), is an enzyme that catalyzes the phosphorylation of D-gluconate, producing 6-phosphogluconate as a result. This reaction is part of the pentose phosphate pathway (PPP), a metabolic pathway parallel to glycolysis, which is crucial for cellular redox balance and biosynthesis.The enzyme, encoded by the GK gene, is unique due to its dual functionality. It acts not only as a gluconokinase but also possesses protein kinase activity. The gluconokinase activity of IDNK is involved in the metabolism of D-gluconate, a sugar acid found in glucose. By converting D-gluconate to 6-phosphogluconate, IDNK facilitates the entry of this metabolite into the PPP, where it can contribute to the generation of NADPH and ribose 5-phosphate. NADPH produced by the PPP is essential for reductive biosynthesis and maintaining the cellular redox state, while ribose 5-phosphate is a precursor for nucleotide synthesis.
The protein kinase activity of IDNK is less well characterized but suggests that the enzyme may have regulatory roles in addition to its metabolic function. This could involve the phosphorylation of specific protein substrates, thereby modulating their activity and influencing various cellular processes.IDNK gluconokinase is expressed in a variety of tissues, indicating that its enzymatic functions are widely required. However, its activity is subject to regulation by glucose levels, as its name suggests. High glucose concentrations inhibit IDNK activity, which helps to balance the flow of glucose and its derivatives through metabolic pathways according to cellular needs.In summary, IDNK gluconokinase is a multifunctional enzyme with activities that integrate metabolic and possibly regulatory roles within the cell, linking nutrient status to metabolic fluxes and potentially to signal transduction pathways. Understanding the full scope of IDNK's functions and regulation may reveal new insights into metabolic control and cellular homeostasis.
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A potent inhibitor of Phosphoinositide 3-kinases, used to block PI3K/Akt signaling pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
A selective inhibitor of MAP kinase kinase (MEK), used to block the MAPK/ERK pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A specific inhibitor of p38 MAPK, used to study inflammation and stress response pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A selective inhibitor of both MEK1 and MEK2, used to block the MAPK/ERK signaling pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), affecting apoptosis and inflammation signaling pathways. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $153.00 | 5 | |
A selective inhibitor of BTK, used in cancer research, particularly for B-cell malignancies. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An inhibitor of mTOR (mammalian target of rapamycin), used to study cell growth and autophagy. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A potent inhibitor of Phosphoinositide 3-kinases, similar to LY294002 but irreversible. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $74.00 | 256 | |
A pan-caspase inhibitor, used to inhibit apoptosis in various research settings. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
A potent inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase, used to study calcium signaling and stress responses. |